Andreas Fibig to leave Bayer
This article was originally published in Scrip
Andreas Fibig, president of Bayer Healthcare Pharmaceuticals and a member of the company's executive committee is to leave the German drugmaker on 1 September 2014. Bayer plans to announce Mr Fibig's successor "in a few days," it said. Mr Fibig, who will become chief executive of New York-based firm International Flavors and Fragrances, has held the post of president since September 2008.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.